SCHEMBL690044

SCHEMBL690044

N=C(N)NCCN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2129107 0.97
Hydrochloric Acid SCHEMBL2305722 0.97
SCHEMBL3079040 0.83 CYP1A2 (0.48)
SCHEMBL11522 0.82
Agmatine SCHEMBL19647 0.80
Agmatine SCHEMBL8579204 0.80 CYP1A2 (0.54)
Hydrochloric Acid SCHEMBL11406144 0.80
Agmatine SCHEMBL5665180 0.80 CYP1A2 (0.54)
Agmatine SCHEMBL30819275 0.80
Bromide SCHEMBL11026848 0.80 CYP1A2 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 174 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4594520-A2 COMPOSITIONS CONTAINING OLIGONUCLEOTIDES WITH THERANOSTIC APPLICATIONS Sixfold Bioscience Ltd. (GB) 2025-08-06 EP claimed
WO-2024069235-A2 COMPOSITIONS CONTAINING OLIGONUCLEOTIDES WITH THERANOSTIC APPLICATIONS Sixfold Bioscience Ltd. (GB) 2024-04-04 WO claimed
US-20230183746-A1 COMPOSITIONS FOR TRANSFER OF CARGO TO CELLS Sixfold Bioscience Ltd. (GB) 2023-06-15 US claimed
CN-113953522-B Electropositive gold nanocluster and preparation method and application thereof 华南师范大学 2023-05-30 CN claimed
EP-4143316-A2 COMPOSITIONS CONTAINING NUCLEIC ACID NANOPARTICLES WITH MODULAR FUNCTIONALITY Sixfold Bioscience Ltd. (GB) 2023-03-08 EP claimed
EP-4022058-A2 COMPOSITIONS FOR TRANSFER OF CARGO TO CELLS Sixfold Bioscience Ltd. (GB) 2022-07-06 EP claimed
CN-113953522-A Electropositive gold nanocluster and preparation method and application thereof 华南师范大学 2022-01-21 CN claimed
WO-2021220053-A2 COMPOSITIONS CONTAINING NUCLEIC ACID NANOPARTICLES WITH MODULAR FUNCTIONALITY Sixfold Bioscience Ltd. (GB) 2021-11-04 WO claimed
US-6906199-B2 Process for preparing distamycin derivatives PHARMACIA ITALIA S.P.A. (IT) 2005-06-14 US claimed
CN-1190418-C Process for preparing distamycin derivatives PHARMACIA ITALIA SPA (IT) 2005-02-23 CN claimed
EP-1347958-B1 PROCESS FOR PREPARING DISTAMYCIN DERIVATIVES PHARMACIA ITALIA SPA (IT) 2005-01-19 EP claimed
US-20040077550-A1 Process for preparing distamycin derivatives NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2004-04-22 US claimed
CN-1476431-A Process for preparing distamycin derivatives 2004-02-18 CN claimed
US-20030232818-A1 Antibacterial compounds ABBVIE INC. 2003-12-18 US claimed
EP-1347958-A1 PROCESS FOR PREPARING DISTAMYCIN DERIVATIVES Pharmacia Italia S.p.A. (IT) 2003-10-01 EP claimed
WO-2002044147-A1 PROCESS FOR PREPARING DISTAMYCIN DERIVATIVES PHARMACIA ITALIA S.P.A. (IT) 2002-06-06 WO claimed
WO-2000009115-A1 GRP RECEPTOR LIGANDS SMITHKLINE BEECHAM CORPORATION (US) 2000-02-24 WO claimed
US-12472267-B2 Compositions containing nucleic acid nanoparticles with modular functionality Sixfold Bioscience Ltd. (GB) 2025-11-18 US disclosed
US-4226852-A ALKALINITY, AMMONIA-FREE, GUANIDINE DERIVATIVE HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1980-10-07 US disclosed
US-4186186-A Guanidine accelerators for peroxide hair bleaching compositions HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) 1980-01-29 US disclosed